Susan Benton serves as Executive at Ocuphire Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Susan Benton has executed 13 insider transactions totaling $91.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 11, 2024 involved receiving (via award) 41,143 shares valued at $0.
Susan Benton currently holds 140,023 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Benton has been a net buyer of OCUP stock. They have purchased $91.4K and sold $0 worth of shares.
Susan Benton's most recent insider trade was on Jun 11, 2024, when they sold 41,143 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 6, 2023 | OCUP | $0 | Award | 10,976 | $N/A | Discretionary |
| Apr 19, 2023 | OCUP | $0 | Award | 1,053 | $N/A | Discretionary |
| Jan 11, 2023 | OCUP | $0 | Award | 16,267 | $N/A | Discretionary |
| Jul 1, 2022 | OCUP | $0 | Award | 12,376 | $N/A | Discretionary |
| Jul 1, 2022 | OCUP | $0 | Award | 6,335 | $N/A | Discretionary |
| Apr 1, 2022 | OCUP | $0 | Award | 3,395 | $N/A | Discretionary |
| Jan 3, 2022 | OCUP | $0 | Award | 2,949 | $N/A | Discretionary |
| Oct 1, 2021 | OCUP | $0 | Award | 2,135 | $N/A | Discretionary |
| Sep 2, 2021 | OCUP | $91.4K | Purchase | 20,000 | $4.57 | Discretionary |
| Jul 1, 2021 | OCUP | $0 | Award | 2,083 | $N/A | Discretionary |
| Apr 1, 2021 | OCUP | $0 | Award | 1,893 | $N/A | Discretionary |